
Commentary|Videos|April 20, 2024
Bempedoic Acid Should be In Everyone's CVD Prevention Toolbox, According to Steven Nissen, MD
Author(s)Grace Halsey
Statin intolerance is a "vexing" problem for primary care clinicians and specialists alike. Bempedoic acid fills a distinct need in that tool box.
Advertisement
"Everyone of us that sees patients has people come in and say, 'Dr Nissen, I tried statins, I cannot tolerate them; I won't take them.'"
Bempedoic acid, with or without ezetimibe, is an option any clinician who treats hyperlipidemia should be comfortable with, Nissen said in a recent interview with Patient Care.®
Nissen is Chief Academic Officer, Heart, Vascular, and Thoracic Institute, Cleveland Clinic, Cleveland, OH and the primary investigator for the bempedoic acid and bempedoic acid plus ezetimibe clinical trial program, including CLEAR Outcomes.
Advertisement
Advertisement
Advertisement
Trending on Patient Care Online
1
Artificial Intelligence ECG Model Identifies Patients at Higher Risk for Sudden Cardiac Death
2
FDA Approves Risankizumab for Pediatric Psoriasis, Psoriatic Arthritis
3
Centanafadine XR Meets Phase 3b ADHD Endpoint in Adults With Comorbid Anxiety
4
FDA Expands Roflumilast Cream 0.3% Approval for Plaque Psoriasis in Children Aged 2 Years and Older
5
















































































































































































































